Grantham, Mayo, Van Otterloo & Co (GMO)
MET icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s MetLife MET Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1M Buy
83,942
+22,688
+37% +$1.83M 0.02% 286
2026
Q1 		$4.33M Sell
61,254
-14,091
-19% -$1.05M 0.01% 343
2025
Q4 		$5.95M Buy
75,345
+539
+0.7% +$42.7K 0.02% 290
2025
Q3 		$6.16M Buy
74,806
+45,447
+155% +$3.58M 0.02% 270
2025
Q2 		$2.36M Buy
29,359
+13,014
+80% +$1M 0.01% 361
2025
Q1 		$1.31M Buy
16,345
+481
+3% +$40K ﹤0.01% 409
2024
Q4 		$1.3M Buy
15,864
+1,044
+7% +$86.9K ﹤0.01% 406
2024
Q3 		$1.22M Buy
+14,820
New +$1.11M ﹤0.01% 412
2023
Q4 		– Sell
-210,589
Closed -$13.2M – 552
2023
Q3 		$13.2M Sell
210,589
-44,658
-17% -$2.78M 0.06% 227
2023
Q2 		$14.4M Buy
255,247
+17,431
+7% +$967K 0.07% 219
2023
Q1 		$13.8M Sell
237,816
-59,700
-20% -$4.03M 0.07% 216
2022
Q4 		$21.5M Sell
297,516
-161,584
-35% -$11.6M 0.11% 171
2022
Q3 		$27.9M Buy
459,100
+11,145
+2% +$712K 0.16% 125
2022
Q2 		$28.1M Sell
447,955
-188,126
-30% -$12.5M 0.15% 136
2022
Q1 		$44.7M Sell
636,081
-124,919
-16% -$8.45M 0.22% 81
2021
Q4 		$47.6M Buy
761,000
+233,700
+44% +$14.7M 0.23% 69
2021
Q3 		$32.5M Buy
527,300
+46,700
+10% +$2.81M 0.16% 105
2021
Q2 		$28.8M Buy
480,600
+29,700
+7% +$1.88M 0.14% 121
2021
Q1 		$27.4M Buy
450,900
+78,700
+21% +$4.34M 0.15% 98
2020
Q4 		$17.5M Buy
+372,200
New +$16.1M 0.11% 133
2017
Q1 		– Sell
-14,398
Closed -$692K – 618
2016
Q4 		$692K Buy
14,398
+2,336
+19% +$107K ﹤0.01% 394
2016
Q3 		$478K Sell
12,062
-6,395
-35% -$240K ﹤0.01% 402
2016
Q2 		$655K Sell
18,457
-5,498
-23% -$214K ﹤0.01% 448
2016
Q1 		$938K Buy
23,955
+5,476
+30% +$205K ﹤0.01% 422
2015
Q4 		$794K Sell
18,479
-75,960
-80% -$3.34M ﹤0.01% 408
2015
Q3 		$3.97M Sell
94,439
-189,203
-67% -$8.84M 0.01% 265
2015
Q2 		$14.2M Sell
283,642
-70,910
-20% -$3.36M 0.05% 162
2015
Q1 		$16M Buy
354,552
+23,750
+7% +$1.07M 0.05% 152
2014
Q4 		$15.9M Sell
330,802
-57,783
-15% -$2.75M 0.04% 158
2014
Q3 		$18.6M Buy
388,585
+57,932
+18% +$2.81M 0.05% 159
2014
Q2 		$16.4M Sell
330,653
-215,993
-40% -$10.1M 0.04% 162
2014
Q1 		$25.7M Sell
546,646
-326,813
-37% -$15M 0.07% 128
2013
Q4 		$42M Sell
873,459
-183,922
-17% -$8.24M 0.1% 103
2013
Q3 		$44.2M Sell
1,057,381
-11,348
-1% -$489K 0.12% 89
2013
Q2 		$43.6M Buy
+1,068,729
New +$39.3M 0.11% 82

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MET Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its MetLife (MET) stake by 37% in Q2 2026, buying an estimated $1.83M and bringing the position to 83,942 shares worth $7.1M. The position accounts for 0.02% of the portfolio, ranked #286.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MET in Q2 2013 and has held it in 35 quarters since. The position peaked at $47.6M in Q4 2021. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 83,942 shares of MetLife worth $7.1M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 22,688 MetLife shares in Q2 2026, an estimated $1.83M.
  • MetLife made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #286 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MetLife in Q2 2013 and has held it in 35 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s MetLife position peaked at $47.6M in Q4 2021.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.